Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy

Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy

Background The impact of estimated glomerular filtration rate (eGFR) on clinical short‐term outcomes after stroke thrombolysis with tissue plasminogen activator remains controversial. Methods and Results We analyzed 18 320 ischemic stroke patients who received intravenous tissue plasminogen activato...

Full description

Bibliographic Details
Main Authors:	Zhen‐Zhen Rao, Hong‐Qiu Gu, Xian‐Wei Wang, Xue‐Wei Xie, Xin Yang, Chun‐Juan Wang, Xingquan Zhao, Ying Xian, Yi‐Long Wang, Zi‐Xiao Li, Rui‐Ping Xiao, Yong‐Jun Wang
Format:	Article
Language:	English
Published:	Wiley 2019-10-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	glomerular filtration rate ischemic stroke outcome renal function tissue‐type plasminogen activator
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.119.012052

Similar Items

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
by: Semai Bek, et al.
Published: (2009-12-01)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
by: Yilin Yang, et al.
Published: (2023-02-01)

The Effect of Homocysteine Levels on Thrombolytic Treatment in Acute Ischemic Stroke
by: Ezgi Yılmaz, et al.
Published: (2022-12-01)

Repeat intravenous r-tPA administration four days after initial thrombolytic therapy for recurrent ischemic stroke: A case report and review of literature
by: Aimen Vanood, et al.
Published: (2021-03-01)

Glomerular Filtration Rate is Associated with Hemorrhagic Transformation in Acute Ischemic Stroke Patients without Thrombolytic Therapy
by: Ming-Su Liu, et al.
Published: (2018-01-01)

Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
by: Xu Tong, et al.
Published: (2020-10-01)

Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke
by: Xu-Dong Cheng, et al.
Published: (2023-06-01)

Intravenous thrombolysis in ischemic stroke: clinical predictors of efficacy and safety
by: Maksim A. Domashenko, et al.
Published: (2019-03-01)

Intravenous thrombolytic for 16 patients with stroke warning syndrome
by: Jing⁃yu PENG
Published: (2020-05-01)

To Treat or Not to Treat: Low‐Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours
by: Wayneho Kam, et al.
Published: (2022-10-01)

Intravenous Thrombolysis Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: Silver Bullet or Useless Bystander?
by: Federico Di Maria, et al.
Published: (2018-09-01)

Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
by: Nabil Mohamed, et al.
Published: (2020-01-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya
by: Mustafa Çetiner, et al.
Published: (2017-12-01)

Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
by: Bing-Hu Li, et al.
Published: (2022-06-01)

Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke
by: Yinghua Jiang, et al.
Published: (2021-09-01)

Association between estimated glomerular filtration rate and clinical outcomes in ischemic stroke patients with high-grade carotid artery stenosis
by: Chung-Hao Chao, et al.
Published: (2021-03-01)

Efficacy and safety of decompressive craniectomy in acute ischemic stroke patients treated with intravenous thrombolysis
by: Elyar Sadeghi-Hokmabadi, et al.
Published: (2023-03-01)

Influence of Estimated Glomerular Filtration Rate on Clinical Outcomes in Patients with Acute Ischemic Stroke Not Receiving Reperfusion Therapies
by: Mi-Yeon Eun, et al.
Published: (2021-10-01)

Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment
by: Mar Castellanos, et al.
Published: (2023-01-01)

Analysis of correlation between diabetes and prognosis in thrombolytic patients with acute ischemic stroke
by: Chun-yang ZHANG, et al.
Published: (2014-11-01)

Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016-06-01)

Intravenous thrombolytic therapy in acute ischemic stroke: The art and science of treatment decision making
by: Sylaja P, et al.
Published: (2008-01-01)

The value of glomerular filtration rate and enlarged perivascular space in the prognosis evaluation of patients with acute ischemic stroke
by: Yi QIU, et al.
Published: (2016-11-01)

Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger
by: Adatia Sweta, et al.
Published: (2010-01-01)

Association of high-estimated glomerular filtration rate with the severity of ischemic stroke during non-vitamin K antagonist oral anticoagulants therapy: a nationwide cohort study
by: Min Kyoung Kang, et al.
Published: (2023-12-01)

Thrombolytic therapy for ischemic stroke
by: Natalia Vyacheslavovna Pizova
Published: (2013-11-01)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
by: Mingfeng Zhai, et al.
Published: (2023-05-01)

Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
by: Andreas Ragoschke-Schumm, et al.
Published: (2017-05-01)

Prediction of unfavorable outcome in ischemic stroke patients with chronic kidney disease
by: A. Antonenko, et al.
Published: (2021-10-01)

Actively developing intravenous thrombolysis for acute ischemic stroke
by: Jin-huan WANG
Published: (2013-04-01)

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy
by: Taku Inohara, et al.
Published: (2019-08-01)

Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke
by: Hongyin Ma, et al.
Published: (2021-01-01)

Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
by: Ike dela Peña, et al.
Published: (2017-01-01)

Ischemic stroke with unknown onset of symptoms: current scenario and perspectives for the future
by: Rônney Pinto Lopes, et al.
Published: (2022-12-01)

Severe Hyperkalemia Masquerading as Acute Ischemic Stroke: A Case Report
by: Zahra Bahrami, et al.
Published: (2022-11-01)

Evaluation of Patients with Ischemic Stroke Receiving iv t-PA in the Emergency Department
by: Omer Salt, et al.
Published: (2018-06-01)

Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke
by: Miaodan Li, et al.
Published: (2018-08-01)

Impact of Stress Hyperglycemia on Early Neurological Deterioration in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
by: Ling Wang, et al.
Published: (2022-05-01)

Risk prediction models for intracranial hemorrhage in acute ischemic stroke patients receiving intravenous alteplase treatment: a systematic review
by: Yaqi Hua, et al.
Published: (2024-01-01)

Clopidogrel-Related High Residual Platelet Reactivity Associated with Estimated Glomerular Filtration Rate in Patients with Acute Ischemic Stroke
by: Yongkang Zhang, et al.
Published: (2023-10-01)